Digital technologies for assessing attention deficit hyperactivity disorder (ADHD)

Evidence-based recommendations on digital technologies for assessing attention deficit hyperactivity disorder (ADHD).

Last reviewed: 21 October 2024

This guidance replaces NICE medtech innovation briefing 318 on QbTest for the assessment of attention deficit hyperactivity disorder (ADHD).

Diagnostics guidance 60 has been migrated to HealthTech guidance 729.

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.

Guidance development process

How we develop NICE HealthTech guidance